My latest email to Hilda - God loves a trier, right?!
Dear Hilda
I was a nice surprise to see the note at the top of the abstract linking to Karla’s news article. Someone said something cryptic on Twitter so I had a look. Rachel Marshall said towards the end of my long campaign to try and get a more prominent link from the review to the news article, that she would try to also link to the information about the update (see her email below). Perhaps you could check with her? I still think it’s awful that the “conclusions changed” tag has disappeared because of the various non-content related notes wiped it out.
From: Rachel Marshall <rmarshall@cochrane.org>
Sent: 24 February 2020 11:58
To: Caroline Struthers <caroline.struthers@csm.ox.ac.uk>
Cc: Karla Soares-Weiser <ksoares-weiser@cochrane.org>
Subject: RE: Exercise for CFS Review
Dear Caroline,
With regard to a link to the new statement about the advisory group lead, we are hoping to have a space on the Cochrane.org website where we include all information about the progress of the update of the ‘Exercise therapy for chronic fatigue syndrome’, including statements and updates on key milestones, so that people can have all information on the review in one space. We will then look to link from the review to this page, so we don’t need to keep going through the amendment process for the review every time there is an update. I’m in discussion with the web team about setting this up now, and I will let you know progress on this.
With regard to the “Related content” link/button in the right-hand panel on the Cochrane review, I’m sorry this was not communicated sooner, but we cannot link to Cochrane news statements from this button. This button can only link to a limited number of Cochrane products that go through a particular production process, such as editorials and podcasts. Technically it is not possible to link to Cochrane news statements from that button.
With best regards, Rachel
Rachel Marshall
Senior Editorial Officer
Editorial & Methods Department | Cochrane Central Executive
As I’ve said before, I don’t think starting again with the same “Exercise for CFS” review question is a good idea. It may be a welcome admission from Cochrane that it got it wrong the first time, but that now includes the review question. Things have moved on, and Cochrane is now flogging a dead horse, and ignoring the ongoing harm to people with ME whilst a new review is in preparation. Also, why ignore the 2008 CBT review on the library with the author’s conclusion “CBT is effective in reducing the symptoms of fatigue at post-treatment compared with usual care”. If you’re going to update the exercise review, it doesn’t make sense to ignore the CBT review which has all the same problems with it and is even more out of date.
It would be more useful to produce an overview of all trials on treatments for ME - GET, CBT, Lightning Process plus therapies outside the BPS domain eg. Ampligen, Chinese medicine (using studies from the recently withdrawn review) etc.. The review could ask the more pressing question of "Why are most of the very few trials on treatments for ME so appalling?" It could focus on objective longer-term outcomes like health services-use, disability payment claims, work/study/society involvement status, and short term objective outcomes physical function etc. plus maybe quality of life amongst the self-reported outcomes. A review like this could shine a much needed spotlight on the fact that most of the studies on psychological/behavioural/woo type interventions for ME use ignore or downplay objective outcomes, use methods such as focusing on subjective outcomes to exaggerate the benefits of these interventions, and under report harms and reasons for drop outs. The overall conclusion about the poor quality of research on behavioural and psychological therapies would be a useful take away which could be applied more generally to improve the quality of primary studies of psychological and behavioural interventions. This would allow Cochrane to partly deliver on its stated aim of advocating for better primary research, the studies on which Cochrane reviews are built. Because primary research is so poor, especially in trials of non-drug interventions, which seem to be held to an even lower standard than drug trials, which have their own issues. Cochrane reviews rarely say anything other than more and better research is needed. If you’re lucky, reviewers indicate what a good primary study should look like. But that is quite rare. This failure to advocate effectively was acknowledged by Mark Wilson himself. I will have to dig out the report where this admission is made. It was probably made in a considerably more subtle way that I remember. But it was made nonetheless.
I wrote a proposal to David Tovey in 2018 which outlined how Cochrane could pursue this idea of advocating for better primary research in partnership with EQUATOR. As further discussions in September 2018 were overtaken by other events, I posted it on my blog.
https://healthycontrolblog.wordpres...help-improve-the-quality-of-primary-research/
With best wishes
Caroline